RAC 7.61% $1.70 race oncology ltd

Ann: Impressive Bisantrene Phase 2 AML Clinical Results, page-84

  1. 18,976 Posts.
    lightbulb Created with Sketch. 5705
    This was a Phase 2 trial. What is impressive about this trial is seeing positive results in such a high percentage of very heavily pre-treated AML patients. You don't fail 4 or more lines of therapy in AML and have a high chance of responding to any treatment.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.70
Change
-0.140(7.61%)
Mkt cap ! $289.4M
Open High Low Value Volume
$1.88 $1.89 $1.70 $456.4K 259.2K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.69
 

Sellers (Offers)

Price($) Vol. No.
$1.70 8662 1
View Market Depth
Last trade - 16.10pm 24/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.